Fellowship : Patient-Oriented Research Awards – Transition to Leadership Stream – Phase 1

Well-being, Health and Biomedical Discovery


Academic Unit: In

Memorial Deadline: Friday 8th, November 2019

External Deadline: Thursday 14th, November 2019


The Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, academic health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care.

The SPOR Capacity Development Initiative

According to the SPOR Capacity Development Framework, patient-oriented research capacity is a collective goal of all SPOR stakeholders. Patient-oriented research capacity means:

  • Patients have the capability and support to meaningfully contribute to and participate in research;
  • The health research enterprise supports viable career paths for patient-oriented researchers and health professionals;
  • All participants in patient-oriented research receive the proper training and support, and all participants should have equitable access to the proper training and support;
  • Patients, researchers, health practitioners, administrators, and policy-makers work collaboratively towards common goals; and,
  • Relevant and transformative knowledge is generated and applied to improve health outcomes.

To this end, SPOR-funded entities (e.g., SPOR SUPPORT Units, SPOR Networks, the SPOR Evidence Alliance, Innovative Clinical Trials (iCT) Initiative Mentorship Chairs and Multi-Year Grant recipients) provide physical or virtual environments to host trainees and researchers, provide localized/contextualized training and scholarships, and promote and advance the science of patient engagement in health research.

Efforts to act on this opportunity have resulted in the SPOR Capacity Development Initiative, which is comprised of the following components:

  • A SPOR National Training Entity (NTE) to serve as a central body for systematic training of patient-oriented research leaders;
  • A suite of national Patient-Oriented Research Awards to support individuals in patient-oriented research:
    1. Transition to Leadership Stream: Trainees transitioning from their research fellowship into independent patient-oriented research careers; and,
    2. Health System Stream: Implementation specialists (as defined above).

The above components will work in concert with each other and collaborate with existing SPOR-funded entities. For more information, please visit the SPOR Capacity Development Initiative web page.

Transition to Leadership Stream

The aim of the Patient-Oriented Research Awards – Transition to Leadership Stream is to support the timely career launch of the next generation of patient-oriented researchers.

The duration of the award is fixed at six years and is comprised of two phases: Phase 1 provides funding for a stipend and research allowance, including professional development training; Phase 2 provides a contribution to the salary and research allowance. Applicants have the flexibility to choose from the following duration options:

  • Two years in Phase 1 and four years in Phase 2; or
  • Three years in Phase 1 and three years in Phase 2.

This funding opportunity is for the Phase 1 portion of the award; it is directed towards promising trainees who will be ready to transition into an independent patient-oriented research career within two to three years from the start of this award.

The funding opportunity for the Phase 2 portion of the award will be launched at a later date. Only Phase 1 award recipients will be able to apply to Phase 2.

Phase 1 award recipients’ learning will be enhanced through unique training opportunities, such as receiving personalized development plan advice and mentorship from the NTE (to be established in Summer 2020), and participating in a national cohort of patient-oriented research trainees and leaders from academic and health system–related organizations. The award recipients’ fellowships will emphasize leadership and focus on the following key knowledge areas and skills for patient-oriented research.

Relevant Research Areas:

This funding opportunity will support research in the following areas:

  1. Transition to Leadership General Pool: This pool will fund applicants in all areas of patient-oriented research.
  2. Indigenous Peoples’ Health Pool: This pool will fund applicants in patient-oriented research who can demonstrate their experience working in an Indigenous Health Research environment, which may include Indigenous living experience, addressing power imbalances and cultural safety.

Funds Available

  • The total amount available for this funding opportunity is $4,650,000, enough to fund approximately twenty (20) awards. This amount may increase if additional funding partners participate.
  • Of this $4,650,000:
    • $3,487,500 is available to fund up to fifteen (15) awards in the Transition to Leadership General Pool.
    • $1,162,500 is available to fund up to five (5) awards relevant to the Indigenous Peoples’ Health Pool.
  • The maximum amount per year for trainees pursuing graduate training is $55,000, for two to three years*.
  • Of this $55,000:
    • Stipend: $50,000 per annum
    • Research allowance: $5,000 per annum
  • The maximum amount per year for trainees pursuing post-doctorate training is $77,500, for two to three years*.
  • Of this $77,500:
    • Stipend: $70,000 per annum
    • Research allowance: $7,500 per annum
  • Phase 1 does not require 1:1 matching of CIHR funds; however, applicants should note that Phase 2 will require 1:1 matching contributions from partners.

* During the application process, the Nominated Principal Applicant will be required to choose a fixed duration for each Phase of their six-year award. Applicants will no longer be able to adjust the duration once it has been chosen. (For example, an applicant may choose to spend three years as a trainee in Phase 1 and three years as an independent researcher in Phase 2; alternatively, an applicant may choose to spend only two years in Phase 1 and have four years of funding in Phase 2**.

** The amount of funding per Phase 2 award is $115,000 per annum and requires 1:1 matching contributions from partners.

Funding Sources

Canadian Institute of Health Research (CIHR)

This opportunity was posted by: RGCS

Last modified: August 6, 2019